Ocean Tomo today announced that it has been retained as the exclusive sales agent by MyoRx Corp. in its divestiture of the MyoRx® product line -- a patent-protected topical analgesic cream containing inflammation-fighting Omega-3 and-Omega 6 fatty acids, aspirin, capsaicin and other antioxidant ingredients.
MyoRx has been distributed in the Pacific Northwest for over twelve years by McKesson Corp. (NYSE: MCK), has over 3,800 active and repeat users, including several NFL teams, and is currently marketed and sold via the MyoRx website (www.myorx.com). MyoRx, unlike other topical analgesics, uses a biological base which penetrates the skin and allows the pain and inflammation fighting ingredients to work at the source of pain. This method, protected by three issued U.S. Patents, centers on utilizing natural Omega Fatty Acids combined with aspirin to deliver pain relief. It is believed MyoRx is the only topical analgesic product currently on the market using a biological base for relieving pain.
An acquisition of the MyoRx product line, which includes the MyoRx product formulas, three U.S. Patents, two U.S. Trademarks, four foreign Trademarks, the MyoRx URL address and other associated assets represents a unique opportunity for numerous industries, including, but not limited to: Pharmaceuticals, Consumer Products, OTC Drug Manufacturers and Nutraceuticals as well as Private Equity or Venture Capital firms.
The MyoRx Product Line will be exclusively marketed by Ocean Tomo’s Private Sale Practice. For more information on the MyoRx product line, please contact David Steinkeler at (312) 327-4415 or dsteinkeler@oceantomo.com.
About Ocean Tomo, LLC
Established in 2003, Ocean Tomo, LLC (www.oceantomo.com) is a fully integrated intellectual capital merchant banc that specializes in understanding and leveraging intellectual property assets. The company provides advice in IP-related mergers and acquisitions, valuations, expert services, analytics and IP auctions. Ocean Tomo has offices in Chicago, San Francisco, Palm Beach, Orange County and Washington, DC. Subsidiaries of Ocean Tomo include: Ocean Tomo Capital, LLC, publisher of the Ocean Tomo 300® Patent Index (Amex:OTPAT); Ocean Tomo Capital Fund, LP -- a private equity investment fund; and Ocean Tomo Asset Management, LLC -- a federally registered investment advisor offering hedge funds utilizing IP-based investment strategies.
